US Stock MarketDetailed Quotes

CDLA Candela Medical

Watchlist

0.000
0.0000.00%

Close Sep 12 09:30 ET

0Market Cap0.00P/E (TTM)

Candela Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2020

(FY)Dec 31, 2019

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

43.45%-17.52M

-30.97M

Net income from continuing operations

-25.80%-43.89M

---34.89M

Operating gains losses

-38.36%810K

--1.31M

Depreciation and amortization

-7.65%16.66M

--18.04M

Deferred tax

-44.45%2.61M

--4.7M

Other non cash items

-563.64%-459K

--99K

Change In working capital

112.95%3.03M

---23.41M

-Change in receivables

240.15%23M

---16.41M

-Change in inventory

114.10%5.12M

---36.31M

-Change in prepaid assets

-168.05%-3.09M

--4.54M

-Change in payables and accrued expense

-224.90%-25.45M

--20.38M

-Change in other working capital

-21.22%3.46M

--4.39M

Cash from discontinued investing activities

Operating cash flow

43.45%-17.52M

---30.97M

Investing cash flow

Cash flow from continuing investing activities

42.32%-11.63M

-20.17M

Net PPE purchase and sale

42.32%-11.63M

---20.17M

Cash from discontinued investing activities

Investing cash flow

42.32%-11.63M

---20.17M

Financing cash flow

Cash flow from continuing financing activities

43.03%58.76M

41.08M

Net issuance payments of debt

869.82%58.97M

--6.08M

Net other financing activities

-100.59%-208K

--35M

Cash from discontinued financing activities

Financing cash flow

43.03%58.76M

--41.08M

Net cash flow

Beginning cash position

-26.91%27.5M

--37.63M

Current changes in cash

394.29%29.61M

---10.06M

Effect of exchange rate changes

2,497.01%1.61M

---67K

End cash Position

113.50%58.72M

--27.5M

Free cash flow

43.00%-29.15M

---51.14M

Currency Unit

USD

USD

Audit Opinions

Unqualified Opinion

--

	(FY)Dec 31, 2020	(FY)Dec 31, 2019
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	43.45%-17.52M	-30.97M
Net income from continuing operations	-25.80%-43.89M	---34.89M
Operating gains losses	-38.36%810K	--1.31M
Depreciation and amortization	-7.65%16.66M	--18.04M
Deferred tax	-44.45%2.61M	--4.7M
Other non cash items	-563.64%-459K	--99K
Change In working capital	112.95%3.03M	---23.41M
-Change in receivables	240.15%23M	---16.41M
-Change in inventory	114.10%5.12M	---36.31M
-Change in prepaid assets	-168.05%-3.09M	--4.54M
-Change in payables and accrued expense	-224.90%-25.45M	--20.38M
-Change in other working capital	-21.22%3.46M	--4.39M
Cash from discontinued investing activities
Operating cash flow	43.45%-17.52M	---30.97M
Investing cash flow
Cash flow from continuing investing activities	42.32%-11.63M	-20.17M
Net PPE purchase and sale	42.32%-11.63M	---20.17M
Cash from discontinued investing activities
Investing cash flow	42.32%-11.63M	---20.17M
Financing cash flow
Cash flow from continuing financing activities	43.03%58.76M	41.08M
Net issuance payments of debt	869.82%58.97M	--6.08M
Net other financing activities	-100.59%-208K	--35M
Cash from discontinued financing activities
Financing cash flow	43.03%58.76M	--41.08M
Net cash flow
Beginning cash position	-26.91%27.5M	--37.63M
Current changes in cash	394.29%29.61M	---10.06M
Effect of exchange rate changes	2,497.01%1.61M	---67K
End cash Position	113.50%58.72M	--27.5M
Free cash flow	43.00%-29.15M	---51.14M
Currency Unit	USD	USD
Audit Opinions	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall